American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT)
Download ReportTranscript American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT)
American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT) P-SATT Leadership Team • Charlie Thompson (Chair), MD FAAP – – – • • Gwen Levy, MD FAAP – – – – – • Member, Executive Committee Program Chair, National Conference & Exhibition General Pediatrics Global Safety Medical Director Amgen Sam Maldonado, MD FAAP – – – • Member, Executive Committee Chair, Membership & Communication Subcommittee Pediatric Critical Care Senior Medical Director, Ikaria Inc Chair, Liaison Subcommittee Pediatric Infectious Diseases Vice President & Head of Pediatric Drug Development Center of Excellence, Janssen Pharmacuetical Companies Andrew Mulberg, MD FAAP – – – – Member, Executive Committee Pediatric Gastroenterology Division Deputy Director, Gastroenterology and Inborn Errors Products Food and Drug Administration Ron Portman, MD FAAP FASN – – – – Chair, Executive Committee General Pediatrics Medical Director, Pfizer Inc Brahm Goldstein, MD MCR FAAP – – – – • • Chuck Schubert, MD MPH FAAP – – – – • Member, Executive Committee Chair, Education Subcommittee Pharmacology Director, Center for Personalized Medicine and Therapeutic Innovation , Children's Mercy Hospital Seth Toback, MD FAAP – – – • Chair, Safety Subcommittee General Pediatrics Senior Medical Director, Patient Safety AstraZeneca Stephen Spielberg, MD PhD FAAP – – – – • Member, Executive Committee Chair, Government Subcommittee Pediatric Nephrology Group Director, Bristol-Myers Squibb Newsletter Editor & ListServ Moderator General Pediatrics Medical Director, MedImmune Paul Wang, MD FAAP – – – – Member, Executive Committee Chair, Research Subcommittee Behavioral and Developmental Pediatrics Vice President, Seaside Therapeutics P-SATT Goals and Objectives • Mission – To advance pediatric health and well-being through collaboration, communication and education on the discovery and development of therapeutics and technology and their successful translation into practice • Goals – Communication • To improve communication and relationships with AAP members within industry, academia and government agencies to create opportunity for dialogue with the organizations that employ them – Education • To educate AAP membership on the discovery, development, and implementation process for therapeutics and technology – Networking • To create a vibrant member community and network that will add value to AAP members • To serve as a resource and integrate expertise with other Sections, Committees and membership-at-large – Integration • To explore the research and development process and make recommendations that will improve quality, safety, understanding and efficiency P-SATT Proposed 2011 Activities • Communication – Develop a dialogue with AAP Leadership on potential areas of collaboration between the AAP, industry, academia, and government agencies (e.g., FDA) • Education – Educate AAP members about drug discovery and development, clinical research and regulatory issues involving new therapeutics and technology for children • Section education program at 2011 AAP on advancing pediatric medicine – Educate AAP members about alternative career paths (e.g., industry, government) • Networking – Develop strategies to recruit AAP members from diverse background into the Section, connect them to each other, and engage them in a meaningful way in the work of the section – Develop liaisons with other AAP sections and committees • Integration – Explore ways to improve the process of drug/device research and development and its translation to everyday practice – Explore relationships between AAP, industry, academia and government agencies (e.g., FDA) How To Join P-SATT • If you are a member of the AAP, please follow the instructions below to join our section – 1) Follow the link to the AAP Member Center • http://www.aap.org/moc/memberservices/sectionform.cfm – 2) Log in as an AAP member – 3) Check the box for “Advances in Therapeutics and Technology” and complete the remainder of the form. • If you are not yet an AAP member but are eligible to join, please follow the link below to join the AAP and then follow the section instructions above – http://www.aap.org/member/memcat.htm